Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV)

References

• BenjaminEJViraniSSCallawayCWAmerican Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke Statistics-2018 update: a report from the American Heart AssociationCirculation201813712e67e49229386200
   PubMed Web of Science ®Google Scholar
• DielemanJLBaralRBirgerMUS spending on personal health care and public health, 1996–2013JAMA2016316242627264628027366
   PubMed Web of Science ®Google Scholar
• FeiginVLForouzanfarMHKrishnamurthiRGlobal Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010 findings from the global burden of Disease Study 2010Lancet2014383991324525524449944
   PubMed Web of Science ®Google Scholar
• SidneySQuesenberryCPJaffeMGRecent trends in cardiovascular mortalityJAMA Cardiol20161559459927438477
   PubMed Web of Science ®Google Scholar
• FalkEPathogenesis of atherosclerosisJ Am Coll Cardiol2006478 SupplC7C1216631513
   PubMed Web of Science ®Google Scholar
• North American Symptomatic Carotid Endarterectomy Trial CollaboratorsBarnettHJMTaylorDWBeneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosisN Engl J Med199132574454531852179
   PubMed Web of Science ®Google Scholar
• BarnettHJTaylorDWEliasziwMBenefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial CollaboratorsN Engl J Med199833920141514259811916
   PubMed Web of Science ®Google Scholar
• SabaLMallariniGA comparison between NASCET and ECST methods in the study of carotids: evaluation using multi-detector-row CT angiographyEur J Radiol2010761424719464837
   PubMedGoogle Scholar
• WalkerMDMarlerJRGoldsteinMEndarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis StudyJAMA199527318142114287723155
   PubMedGoogle Scholar
• FarrellBFraserASanfercockPSlatteryJWarlowCPRandomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)Lancet19983519113137913879593407
   PubMedGoogle Scholar
• FlahertyMLKisselaBKhouryJCCarotid artery stenosis as a cause of strokeNeuroepidemiology2013401364123075828
   PubMed Web of Science ®Google Scholar
• Lovrencic-HuzjanARundekTKatsnelsonMRecommendations for management of patients with carotid stenosisStroke Res Treat2012201212112
   Google Scholar
• GrantEGBensonCBMonetaGLCarotid artery stenosis: gray-scale and Doppler US diagnosis – Society of Radiologists in Ultrasound Consensus ConferenceRadiology2003229234034614500855
   PubMed Web of Science ®Google Scholar
• MarksSJKheraSCryptogenic stroke: making the management less crypticCardiol Rev201624415315725867760
   PubMedGoogle Scholar
• FonsecaACFerroJMCryptogenic strokeEur J Neurol201522461862325597418
   PubMedGoogle Scholar
• KhatriPKleindorferDODevlinTPRISMS InvestigatorsEffect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the prisms randomized clinical trialJAMA2018320215616629998337
   PubMed Web of Science ®Google Scholar
• SavitzSIBaronJCYenariMASanossianNFisherMMidoriAReconsidering neuroprotection in the reperfusion eraStroke201748123413341929146878
   PubMedGoogle Scholar
• KamelHLongstrethWTTirschwellDLThe atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methodsInt J Stroke201914220721430196789
   PubMed Web of Science ®Google Scholar
• AkobengAKAbdelgadirIBoudjemlineYHijaziZMPatent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trialsCatheter Cardiovasc Interv2018921165173
   PubMedGoogle Scholar
• DarmochFAl-KhadraYSoudMFanariZAlraiesMCTranscatheter closure of patent foramen ovale versus medical therapy after cryptogenic stroke: a meta-analysis of randomized controlled trialsCerebrovasc Dis2018453–416216929597192
   PubMed Web of Science ®Google Scholar
• MarcinkiewiczCGerstenhaberJAMark SternbergMLelkesPIFeuersteinGBitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor αIIbβ3 and activated plateletsInt J Nanomedicine2017128471848229200855
   PubMedGoogle Scholar
• GerstenhaberJABaroneFCMarcinkiewiczCVascular thrombus imaging in vivo via near-infrared fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (part II)Int J Nanomedicine2017128471848229200855
   PubMed Web of Science ®Google Scholar
• BaroneFCMarcinkiewiczCLiJPilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)Int J Nanomedicine2018135449546830271140
   PubMed Web of Science ®Google Scholar
• ZhouJZhuangJLiJLong-term post-stroke changes include myelin loss, specific deficits in sensory and motor behaviors and complex cognitive impairment detected using active place avoidancePLoS One201383e5750323505432
   PubMedGoogle Scholar
• ZhouJLiJRosenbaumDMThe prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsPLoS One2017129e018404928880966
   PubMed Web of Science ®Google Scholar
• ChanutFKimbroughCHaileyRSpontaneous cardiomyopathy in young Sprague-Dawley rats: evaluation of biological and environmental variabilityToxicol Pathol20134181126113623475560
   PubMedGoogle Scholar
• BartholdSWChronic progressive nephropathy in aging ratsToxicol Pathol19797116
   Google Scholar
• PurtovKPetuninAInzhevatkinEBiodistribution of different sized nanodiamonds in miceJ Nanosci Nanotechnol20151521070107526353614
   PubMed Web of Science ®Google Scholar
• MooreLYangJLanTTBiocompatibility assessment of detonation nanodiamond in non-human primates and rats using histological, hematologic, and urine analysisACS Nano20161087385740027439019
   PubMed Web of Science ®Google Scholar
• RojasSGispertJDMartínRBiodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emissionACS Nano2011575552555921657210
   PubMed Web of Science ®Google Scholar
• BhattacharyaKMukherjeeSPGalludABiological interactions of carbon-based nanomaterials: from coronation to degradationNanomedicine201612233335126707820
   PubMed Web of Science ®Google Scholar
• AnderssonBThurnherrTKunzmannAAToxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradationBiochim Biophys Acta18103201136137320435096
   PubMedGoogle Scholar
• MochalinVNShenderovaOHoDGogotsiYThe properties and applications of nanodiamondsNat Nanotechnol2012711123
   Web of Science ®Google Scholar
• VaijayanthimalaVChengPYYehSHThe long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agentBiomaterials201233317794780222863379
   PubMed Web of Science ®Google Scholar
• MonopoliMPÅbergCSalvatiADawsonKABiomolecular coronas provide the biological identity of nanosized materialsNat Nanotechnol201271277978623212421
   PubMed Web of Science ®Google Scholar
• KellyPMÅbergCPoloEMapping protein binding sites on the biomolecular corona of nanoparticlesNat Nanotechnol201510547247925822932
   PubMed Web of Science ®Google Scholar
• Hamad-SchifferliKExploiting the novel properties of protein coronas: emerging applications in nanomedicineNanomedicine (Lond)201510101663167426008198
   PubMedGoogle Scholar